CPRiL

C12H15NO5S

C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)[C@H]3CCCO3)C(=O)O)O

InChI=1S/C12H15NO5S/c1-5(14)7-10(15)13-8(12(16)17)9(19-11(7)13)6-3-2-4-18-6/h5-7,11,14H,2-4H2,1H3,(H,16,17)/t5-,6-,7+,11-/m1/s1

• faropenem
• Fropenem
• Faropenem [USAN:INN]
(5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
UNII-F52Y83BGH3
DTXSID0046430
FAROPENEM [INN]
FAROPENEM [MI]
FAROPENEM [WHO-DD]
DTXCID8026430
6alpha-[(1R)-1-hydroxyethyl]-2-[(2R)-tetrahydrofuran-2-yl]-2,3-didehydropenam-3-carboxylic acid
compound 1 [PMID: 9216830]
6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid
compound 1 (PMID: 9216830)
4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 6-((1R)-1-HYDROXYETHYL)-7-OXO-3-((2R)-TETRAHYDRO-2-FURANYL)-,(5R,6S)
CHEBI:51788
faropenemum
6alpha-((R)-1-hydroxyethyl)-2-((R)-tetrahydrofuran-2-yl)pen-2-em-3-carboxylic acid
(5R,6S)-6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-oxolan-2-yl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
6alpha-((1R)-1-hydroxyethyl)-2-((2R)-tetrahydrofuran-2-yl)-2,3-didehydropenam-3-carboxylic acid
J01DI03
6-(1-hydroxyethyl)-2-((2R)-tetrahydrofuran-2-yl)-2,3-didehydropenam-3-carboxylic acid
6-(1-hydroxyethyl)-2-[(2R)-tetrahydrofuran-2-yl]-2,3-didehydropenam-3-carboxylic acid
faropenem medoxil\nfaropenem medoxil
(5R,6S,8R,2'R)-2-(2'-tetrahydrofuryl)-6-hydroxyethylpenem-3-carboxylate
(5R,6S)-6-(R)-1-hydroxyethyl-7-oxo-3-(R)-2-tetrahydrofuryl-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylate
(5r)-6-(1-hydroxyethyl)-7-oxo-3-((2r)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
(5r)-6-(1-hydroxyethyl)-7-oxo-3-[(2r)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
106560-14-9
CHEBI:51257